High-flow nasal cannula for the treatment of life-threatening plastic bronchitis

Area of Science:

• Pediatric Cardiology
• Respiratory Medicine
• Medical Technology

Background:

• Plastic bronchitis (PB) is a rare condition characterized by the formation of obstructive bronchial casts.
• It predominantly affects children, frequently occurring after the Fontan procedure for congenital heart disease.
• Existing therapies for PB show variable success rates.

Observation:

• A pediatric patient with plastic bronchitis post-Fontan procedure experienced recurrent bronchial cast formation.
• Conventional treatments provided limited long-term efficacy in preventing cast recurrence.
• The patient's clinical condition necessitated exploration of alternative therapeutic strategies.

Findings:

• Overnight use of a home high-flow nasal cannula (HFNC) was implemented as a novel therapeutic intervention.
• This approach demonstrated success in preventing the recurrence of bronchial cast production.
• This represents the first reported instance of HFNC for managing PB in this specific patient population.

Implications:

• Home high-flow nasal cannula therapy presents a promising, non-invasive option for managing plastic bronchitis.
• This intervention may improve outcomes and reduce the burden of recurrent cast formation in children post-Fontan.
• Further research is warranted to validate the efficacy and long-term benefits of HFNC in pediatric PB.